ANIK logo

Anika Therapeutics (ANIK) Free Cash Flow

ANIK Annual FCF

-$7.21 M
-$4.14 M-134.48%

31 December 2023

ANIK Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIK Quarterly FCF

$3.20 M
+$7.67 M+171.56%

30 September 2024

ANIK Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIK TTM FCF

-$1.41 M
-$2.54 M-223.94%

30 September 2024

ANIK TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIK Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-134.5%-44.3%+87.3%
3 y3 years-163.1%+311.3%-168.8%
5 y5 years-123.8%-66.8%-104.1%

ANIK Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-321.7%at low-44.3%+132.8%-143.3%+91.1%
5 y5-year-121.1%at low-74.9%+132.8%-104.1%+91.1%
alltimeall time-118.8%+43.8%-83.5%+130.1%-103.7%+94.0%

Anika Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
$3.20 M(-171.6%)
-$1.41 M(-223.9%)
June 2024
-
-$4.47 M(+131.2%)
$1.14 M(-127.4%)
Mar 2024
-
-$1.93 M(-207.6%)
-$4.14 M(-42.6%)
Dec 2023
-$7.21 M(+134.5%)
$1.80 M(-68.7%)
-$7.21 M(-34.8%)
Sept 2023
-
$5.74 M(-158.9%)
-$11.06 M(-29.9%)
June 2023
-
-$9.75 M(+94.7%)
-$15.79 M(+222.9%)
Mar 2023
-
-$5.01 M(+144.5%)
-$4.89 M(+58.9%)
Dec 2022
-$3.08 M(-194.6%)
-$2.05 M(-301.2%)
-$3.08 M(-232.9%)
Sept 2022
-
$1.02 M(-11.3%)
$2.32 M(+11.6%)
June 2022
-
$1.15 M(-135.9%)
$2.08 M(-28.6%)
Mar 2022
-
-$3.19 M(-195.5%)
$2.91 M(-10.7%)
Dec 2021
$3.25 M(-71.5%)
$3.35 M(+329.9%)
$3.25 M(+59.0%)
Sept 2021
-
$778.00 K(-60.7%)
$2.05 M(-70.2%)
June 2021
-
$1.98 M(-169.5%)
$6.86 M(-17.0%)
Mar 2021
-
-$2.85 M(-233.2%)
$8.27 M(-27.7%)
Dec 2020
$11.44 M(-66.5%)
$2.14 M(-61.8%)
$11.44 M(-48.1%)
Sept 2020
-
$5.59 M(+65.4%)
$22.05 M(-15.4%)
June 2020
-
$3.38 M(+950.6%)
$26.08 M(-3.6%)
Mar 2020
-
$322.00 K(-97.5%)
$27.07 M(-20.8%)
Dec 2019
$34.18 M(+12.9%)
$12.75 M(+32.5%)
$34.18 M(+9.3%)
Sept 2019
-
$9.62 M(+120.3%)
$31.27 M(-0.0%)
June 2019
-
$4.37 M(-41.2%)
$31.28 M(+2.1%)
Mar 2019
-
$7.43 M(-24.5%)
$30.64 M(+1.3%)
Dec 2018
$30.26 M(-4.9%)
$9.85 M(+2.3%)
$30.26 M(+21.4%)
Sept 2018
-
$9.63 M(+158.2%)
$24.92 M(+0.5%)
June 2018
-
$3.73 M(-47.1%)
$24.80 M(-1.2%)
Mar 2018
-
$7.05 M(+56.4%)
$25.10 M(-21.2%)
Dec 2017
$31.83 M(+205.1%)
$4.51 M(-52.6%)
$31.83 M(-0.5%)
Sept 2017
-
$9.51 M(+136.1%)
$31.99 M(+3.0%)
June 2017
-
$4.03 M(-70.8%)
$31.05 M(+37.5%)
Mar 2017
-
$13.79 M(+195.6%)
$22.59 M(+116.5%)
Dec 2016
$10.43 M(-66.0%)
$4.66 M(-45.6%)
$10.43 M(-29.0%)
Sept 2016
-
$8.58 M(-293.5%)
$14.69 M(+4.0%)
June 2016
-
-$4.43 M(-372.6%)
$14.13 M(-50.6%)
Mar 2016
-
$1.63 M(-81.8%)
$28.58 M(-6.9%)
Dec 2015
$30.69 M(-20.1%)
$8.92 M(+11.4%)
$30.69 M(-14.5%)
Sept 2015
-
$8.01 M(-20.1%)
$35.88 M(+2.5%)
June 2015
-
$10.02 M(+168.8%)
$35.02 M(+21.4%)
Mar 2015
-
$3.73 M(-73.6%)
$28.83 M(-25.0%)
Dec 2014
$38.42 M(+55.4%)
$14.12 M(+97.7%)
$38.42 M(+19.7%)
Sept 2014
-
$7.14 M(+86.0%)
$32.10 M(-0.8%)
June 2014
-
$3.84 M(-71.2%)
$32.36 M(+1.1%)
Mar 2014
-
$13.32 M(+70.8%)
$32.01 M(+29.5%)
Dec 2013
$24.72 M(+173.4%)
$7.80 M(+5.4%)
$24.72 M(+14.9%)
Sept 2013
-
$7.40 M(+112.0%)
$21.52 M(+33.0%)
June 2013
-
$3.49 M(-42.2%)
$16.18 M(-4.8%)
Mar 2013
-
$6.03 M(+31.1%)
$16.99 M(+87.9%)
Dec 2012
$9.04 M(+3.1%)
$4.60 M(+123.9%)
$9.04 M(-20.0%)
Sept 2012
-
$2.05 M(-52.3%)
$11.30 M(-5.2%)
June 2012
-
$4.30 M(-324.9%)
$11.93 M(+111.1%)
Mar 2012
-
-$1.91 M(-127.9%)
$5.65 M(-35.6%)
Dec 2011
$8.77 M(+73.1%)
$6.86 M(+156.2%)
$8.77 M(+86.1%)
Sept 2011
-
$2.68 M(-235.6%)
$4.71 M(+3.9%)
June 2011
-
-$1.98 M(-263.4%)
$4.54 M(-35.6%)
Mar 2011
-
$1.21 M(-56.8%)
$7.04 M(+39.0%)
Dec 2010
$5.07 M(-684.3%)
$2.80 M(+12.1%)
$5.07 M(+3.8%)
Sept 2010
-
$2.50 M(+369.0%)
$4.88 M(+178.9%)
June 2010
-
$533.00 K(-169.6%)
$1.75 M(+138.7%)
Mar 2010
-
-$766.00 K(-129.3%)
$733.40 K(-184.5%)
Dec 2009
-$867.50 K(-93.2%)
$2.62 M(-513.7%)
-$867.60 K(-76.4%)
Sept 2009
-
-$632.40 K(+30.5%)
-$3.67 M(-26.1%)
June 2009
-
-$484.50 K(-79.5%)
-$4.97 M(-50.8%)
Mar 2009
-
-$2.37 M(+1180.2%)
-$10.09 M(-21.4%)
DateAnnualQuarterlyTTM
Dec 2008
-$12.84 M(+25.1%)
-$184.90 K(-90.4%)
-$12.84 M(-44.9%)
Sept 2008
-
-$1.93 M(-65.6%)
-$23.30 M(+14.8%)
June 2008
-
-$5.61 M(+9.7%)
-$20.30 M(+36.0%)
Mar 2008
-
-$5.11 M(-52.0%)
-$14.93 M(+45.4%)
Dec 2007
-$10.26 M(-1575.8%)
-$10.65 M(-1088.5%)
-$10.26 M(+5880.7%)
Sept 2007
-
$1.08 M(-544.4%)
-$171.60 K(-70.8%)
June 2007
-
-$242.40 K(-46.1%)
-$586.80 K(-154.0%)
Mar 2007
-
-$449.90 K(-19.2%)
$1.09 M(+56.4%)
Dec 2006
$695.40 K(-85.7%)
-$556.50 K(-184.1%)
$695.30 K(+750.0%)
Sept 2006
-
$662.00 K(-53.8%)
$81.80 K(-98.5%)
June 2006
-
$1.43 M(-270.0%)
$5.35 M(+70.1%)
Mar 2006
-
-$842.10 K(-28.0%)
$3.15 M(-35.2%)
Dec 2005
$4.85 M(-79.2%)
-$1.17 M(-119.7%)
$4.85 M(-56.6%)
Sept 2005
-
$5.93 M(-866.0%)
$11.17 M(+101.7%)
June 2005
-
-$774.40 K(-189.7%)
$5.54 M(+15.4%)
Mar 2005
-
$863.50 K(-83.2%)
$4.80 M(-79.5%)
Dec 2004
$23.35 M(+1229.8%)
$5.15 M(+1621.8%)
$23.35 M(+12.7%)
Sept 2004
-
$299.00 K(-119.7%)
$20.72 M(-4.6%)
June 2004
-
-$1.51 M(-107.8%)
$21.72 M(+0.1%)
Mar 2004
-
$19.42 M(+671.5%)
$21.69 M(+1135.0%)
Dec 2003
$1.76 M(+622.6%)
$2.52 M(+94.1%)
$1.76 M(+189.3%)
Sept 2003
-
$1.30 M(-183.9%)
$607.00 K(-192.9%)
June 2003
-
-$1.55 M(+202.0%)
-$653.40 K(-290.7%)
Mar 2003
-
-$512.00 K(-137.4%)
$342.70 K(+41.0%)
Dec 2002
$243.00 K(-104.7%)
$1.37 M(+3637.7%)
$243.00 K(-112.2%)
Sept 2002
-
$36.60 K(-106.7%)
-$2.00 M(-46.9%)
June 2002
-
-$549.90 K(-10.1%)
-$3.76 M(-13.3%)
Mar 2002
-
-$611.70 K(-29.7%)
-$4.33 M(-17.0%)
Dec 2001
-$5.22 M(+118.6%)
-$870.30 K(-49.6%)
-$5.22 M(+30.0%)
Sept 2001
-
-$1.73 M(+53.3%)
-$4.02 M(+15.2%)
June 2001
-
-$1.13 M(-24.9%)
-$3.49 M(+5.6%)
Mar 2001
-
-$1.50 M(-547.0%)
-$3.30 M(+38.3%)
Dec 2000
-$2.39 M(+157.5%)
$335.50 K(-128.0%)
-$2.39 M(-24.2%)
Sept 2000
-
-$1.20 M(+27.0%)
-$3.15 M(+39.7%)
June 2000
-
-$941.80 K(+60.7%)
-$2.26 M(-6.6%)
Mar 2000
-
-$585.90 K(+37.0%)
-$2.41 M(+160.2%)
Dec 1999
-$927.70 K(-177.3%)
-$427.70 K(+42.6%)
-$927.70 K(+827.7%)
Sept 1999
-
-$300.00 K(-72.7%)
-$100.00 K(-110.0%)
June 1999
-
-$1.10 M(-222.2%)
$1.00 M(-67.7%)
Mar 1999
-
$900.00 K(+125.0%)
$3.10 M(+158.3%)
Dec 1998
$1.20 M(-47.8%)
$400.00 K(-50.0%)
$1.20 M(-65.7%)
Sept 1998
-
$800.00 K(-20.0%)
$3.50 M(+34.6%)
June 1998
-
$1.00 M(-200.0%)
$2.60 M(+36.8%)
Mar 1998
-
-$1.00 M(-137.0%)
$1.90 M(-26.9%)
Dec 1997
$2.30 M(-330.0%)
$2.70 M(-2800.0%)
$2.60 M(-360.0%)
Sept 1997
-
-$100.00 K(-133.3%)
-$1.00 M(-33.3%)
June 1997
-
$300.00 K(-200.0%)
-$1.50 M(-21.1%)
Mar 1997
-
-$300.00 K(-66.7%)
-$1.90 M(-17.4%)
Dec 1996
-$1.00 M(-50.0%)
-
-
Nov 1996
-
-$900.00 K(+50.0%)
-$2.30 M(+15.0%)
Aug 1996
-
-$600.00 K(+500.0%)
-$2.00 M(+11.1%)
Aug 1996
-$2.00 M(0.0%)
-
-
May 1996
-
-$100.00 K(-85.7%)
-$1.80 M(-21.7%)
Feb 1996
-
-$700.00 K(+16.7%)
-$2.30 M(+15.0%)
Nov 1995
-
-$600.00 K(+50.0%)
-$2.00 M(0.0%)
Aug 1995
-$2.00 M(-23.1%)
-$400.00 K(-33.3%)
-$2.00 M(-16.7%)
May 1995
-
-$600.00 K(+50.0%)
-$2.40 M(+20.0%)
Feb 1995
-
-$400.00 K(-33.3%)
-$2.00 M(-23.1%)
Nov 1994
-
-$600.00 K(-25.0%)
-$2.60 M(0.0%)
Aug 1994
-$2.60 M(+36.8%)
-$800.00 K(+300.0%)
-$2.60 M(+44.4%)
May 1994
-
-$200.00 K(-80.0%)
-$1.80 M(+12.5%)
Feb 1994
-
-$1.00 M(+66.7%)
-$1.60 M(+166.7%)
Nov 1993
-
-$600.00 K
-$600.00 K
Aug 1993
-$1.90 M
-
-

FAQ

  • What is Anika Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Anika Therapeutics?
  • What is Anika Therapeutics annual FCF year-on-year change?
  • What is Anika Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Anika Therapeutics?
  • What is Anika Therapeutics quarterly FCF year-on-year change?
  • What is Anika Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Anika Therapeutics?
  • What is Anika Therapeutics TTM FCF year-on-year change?

What is Anika Therapeutics annual free cash flow?

The current annual FCF of ANIK is -$7.21 M

What is the all time high annual FCF for Anika Therapeutics?

Anika Therapeutics all-time high annual free cash flow is $38.42 M

What is Anika Therapeutics annual FCF year-on-year change?

Over the past year, ANIK annual free cash flow has changed by -$4.14 M (-134.48%)

What is Anika Therapeutics quarterly free cash flow?

The current quarterly FCF of ANIK is $3.20 M

What is the all time high quarterly FCF for Anika Therapeutics?

Anika Therapeutics all-time high quarterly free cash flow is $19.42 M

What is Anika Therapeutics quarterly FCF year-on-year change?

Over the past year, ANIK quarterly free cash flow has changed by -$2.54 M (-44.29%)

What is Anika Therapeutics TTM free cash flow?

The current TTM FCF of ANIK is -$1.41 M

What is the all time high TTM FCF for Anika Therapeutics?

Anika Therapeutics all-time high TTM free cash flow is $38.42 M

What is Anika Therapeutics TTM FCF year-on-year change?

Over the past year, ANIK TTM free cash flow has changed by +$9.65 M (+87.27%)